White blood cells (WBC) >  x ^/L, within  days prior to administration of study treatment
White blood cells (WBC) >  x ^/L, measured within  days prior to administration of study treatment
Measured within  days prior to registration: white blood cells > ,/mcL
More than % white blood cells in bone marrow.
White blood cells (WBC) > , cells/mcL ( cells x ^/L) at screening. In subjects with WBC > , cells/mcL at screening with lymphocyte predominance, subject may be deemed eligible for the trial by the Amgen physician, after discussion with the investigator.
White blood cells (WBC) >= . x ^/L
White blood cells (WBC) >  x ^/L
Total white blood cells (WBC) < x^/L (/mm^)
White blood cells (WBC) < ,
White blood cells (WBC) >=  x ^/L, completed within  days prior to the date of registration
White blood cells >= ,/microliter
White blood cells (WBC) >= /mm^
White blood cells (WBC) >= ,/mm^
White blood cells (WBC) > , cells/mcL at screening
White blood cells (WBC) >= ,/mm^
White blood cells (WBC) >= /mm^
PART I: White blood cell (WBC) >= , cells/mm^
White blood cells (WBC) (> /mm^)
White blood cells (WBC) >= .
White blood cells (WBC) > ,/mcL
Normal white blood cells (WBC) (> /mm^)
White blood cells (WBC) >= /mm^
Within  days prior to administration of study treatment: White blood cells (WBC) >  x ^/L.
White blood cell (WBC) >=  x ^ cells/mL
White blood cells (WBC) >= /mm^
White blood cells (WBC) >  x ^/L
White blood cells (WBC) >=  x ^ cells/mL
White Blood Cell (WBC) ?  cells/mm
White blood cells (WBC) >= /mm^ within  days of enrollment to study
White blood cells (WBC) >= ,/mcL
Circulating white blood cells < . /L (with or without use of hydroxycarbamide).
White blood cells (WBC) =<  x ^/L
White blood cells (WBC) > , cells/mm^
White blood cells (WBC) >= ,/mcL
White blood cells (WBC) >= /mm^
White blood cells (WBC) >= . x ^/L
White blood cells >= /mm^
White blood cells (WBC) >=  x ^ cells/ml
White blood cells (WBC) >= ,/mcL
White blood cells (WBC) > /mm^
White blood cells (WBC) < /mcl
Within  weeks of day : White blood cells (WBC) >= /mm^
White blood cells (WBC) > x^/L (measured within  days prior to administration of study treatment)
White blood cells (WBC) > .
White blood cells (WBC) < . K/mcL
White blood cell (WBC) >=  cells/mm^ or >= . bil/L
White blood cells (WBC) > /mm^
White blood cells (WBC) >= . x ^/L
Within  days of first vaccination: White blood cells (WBC) >= /mm^
White blood cells (WBC) >= /mm^
White blood cells (WBC) >= /mm^
White blood cells (WBC) >= /mm^
White blood cells (WBC) >= .
White blood cells (WBC) >= ,/mm^
White blood cell (WBC) >=  cells/mm^ or >= . bil/L
White blood cells (WBC) >= .
White blood cells (WBC) >= ,/mcL
White blood cells (WBC) >= /mm^
White blood cells (WBC) >= ,/mm^
White blood cells (WBC) >= /mm^
White blood cells (WBC) >= /mm^
White blood cells (WBC) >= ,/mm^
Peripheral blood leukocyte count (white blood cells [WBC]) < /mm^.
White blood cell (WBC) ?  cells/mm^ ?  weeks
White blood cells (WBC) >= ,/mcL
White blood cells (WBC) > /mcL
DONOR: White blood cells (WBC), platelet count near normal limits ( %)
White blood cells (WBC) >= /mm^
White blood cells (WBC) >  x ^/L, measured within  days prior to administration of study treatment
White blood cells (WBC) of  per mcL
White blood cells (WBC) >= . x ^/L
White blood cell (WBC) > , cells/mm^
White blood cells (WBC) > ,/mcL
White blood cells (WBC) >= ,/mcL
White blood cells (WBC) > . ml
White blood cells (WBC) >= /mm^
White blood cells (WBC) >= . x ^ cells/L
White blood cells (WBC) >= /mm^ within  weeks of enrollment
White blood cell (WBC) must be >  cells/mm^
White blood cell (WBC) >=  cells/mm^ or >= . bil/L
White blood cell (WBC) >=  cells/mm^ or >= . bil/L
White blood cells (WBC) < .
STEP  ENROLLMENT AND RANDOMIZATION: white blood cells (WBC) >= ,/mm^ within  weeks of study entry
Patients receiving hydroxyurea may continue receiving it for up to  days after the start of protocol treatment if white blood cells (WBC) >  x^/L
White blood cells (WBC) >= /mm^
White blood cells (WBC) < ,/mm^
White blood cells (WBC) >= /mm^
White blood cells (WBC) >= /mm^
DONOR: white blood cells (WBC) .-. x ^/mm^
White blood cells (WBC) >= /mm^
White Blood Cells (WBC) ? .xE/L including
White blood cells (WBC) (> /mm^)
White blood cells ? /L
White blood cells (WBC) >= .
White blood cells (WBC) < ./ml
White blood cells (WBC) >= ,/mL
White blood cells (WBC) >= , cells/mm^
White blood cells (WBC) >= /mm^
White blood cells (WBC) >= /mm^
White blood cells (WBC) < ,
White blood cells >= ,/mcL
White blood cells (WBC) >=  x ^/L, transfusions and growth factors are allowed
Total white blood cells (WBC) >= . x ^/mcL within  days prior to registration
White blood cells >= ,/microliter
White blood cells (WBC) within institutional limits of normal or judged to be not clinically significant by the investigator
Peripheral blood white blood cells (WBC) greater than , per microliter (required for collection of dendritic cell precursors)
White blood cells (WBC) >= /mm^
